A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...

Neurogene's stock price collapsed by 34.8% in pre-market trading after announcing data from the Phase I/II Rett syndrome ...

Neurogene reports interim Phase 1/2 trial results for NGN-401 gene therapy in treating pediatric Rett syndrome, showing ...

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

When looking at Neurogene’s stock performance year-to-date, it’s hard to ignore the impressive +269.09% increase. However, this recent downturn suggests that the market is responding to something ...

Gail Rich's daughters Jessica and Nicole were both diagnosed with a rare and incurable neurodegenerative condition, commonly known as Batten Disease. The family's battle for funding and access to ...

Fifth disease, also known as erythema infectiosum, is a contagious viral illness caused by parvovirus B19. It is most common in children, but it can also affect adults. The main symptom of fifth ...

Oct. 30, 2024 — Chronic, low-level lead poisoning is a major risk factor for cardiovascular disease in adults and cognitive deficits in children, even at levels previously thought to be safe ...

Cardiovascular disease is a group of conditions that affect your heart and blood vessels. It's sometimes also called heart disease. Conditions that affect your heart and blood vessels can include ...

Analyst Mitchell Kapoor of H.C. Wainwright reiterated a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report), retaining the ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...